June 30, 2024
Headlines

Healthtech

DiaMedica Therapeutics Secures $11.8 Million Investment to Advance Breakthrough Treatments

Editor04 mins

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a pioneering biopharmaceutical firm renowned for its innovative approach to severe ischemic diseases, has announced a significant milestone today. The company successfully finalized agreements for a private placement offering, securing $11.8 million in gross proceeds from accredited investors. This strategic funding round underscores DiaMedica’s commitment to advancing clinical and product…

Read More

Cryogenx Secures £800,000 to Revolutionize Heatstroke Treatment with Innovative Cooling Device

Editor05 mins

London-based healthtech startup Cryogenx has successfully raised £800,000 in funding to advance its groundbreaking portable body cooling device, CGX1. This investment round includes a significant contribution of £150,000 from the British Design Fund, alongside support from existing shareholders, angel investors, and a US-based fund. Founded by Matt Anderson, Cryogenx aims to address the critical need…

Read More

Zuub Secures $9M Series A Funding to Revolutionize Dental Revenue Cycle Automation

Editor05 mins

Zuub, a trailblazer in dental Revenue Cycle Automation, has marked a significant milestone with the closing of a $9 million Series A funding round. Led by Vertical Venture Partners, with participation from existing investors Bonfire Ventures and MTech Capital, this funding underscores Zuub’s commitment to transforming dental practice operations through advanced artificial intelligence and automation…

Read More

Merck Global Health Innovation Fund Invests in Qure.ai to Propel Healthcare AI Innovations

Editor04 mins

Qure.ai Technologies Limited has secured a significant strategic investment from the Merck Global Health Innovation Fund in its latest Series D funding round. This partnership marks a pivotal moment for advancing artificial intelligence (AI) in healthcare, particularly in the realm of medical imaging. Qure.ai, renowned for its groundbreaking AI applications, including early detection tools for…

Read More

UroMems Raises $47 Million in Series C Funding to Advance Groundbreaking Treatment for Stress Urinary Incontinence

Editor05 mins

UroMems, a pioneering global company specializing in mechatronics technology for treating stress urinary incontinence (SUI), has secured $47 million in its Series C financing round, marking a record fundraising achievement for the company. This capital infusion will propel pivotal clinical trials of their groundbreaking UroActive™ System, the world’s first smart automated artificial urinary sphincter (AUS)…

Read More
cureosity_team

CUREOSITY Secures €3.8 Million Investment to Propel VR Therapy Innovations

Editor06 mins

In a significant stride towards revolutionizing therapeutic interventions, medtech innovator CUREOSITY has announced securing an additional €3.8 million in funding, catapulting its total investment to over €8.4 million. Specializing in the development of virtual reality (VR) therapy enhanced by gamification, CUREOSITY integrates cutting-edge neuroscientific discoveries, particularly harnessing the power of neuroplasticity, with decades of therapeutic…

Read More

EpilepsyGTx Secures $10M to Advance Breakthrough Gene Therapy for Focal Refractory Epilepsy

Editor05 mins

EpilepsyGTx, a pioneering biotechnology firm specializing in advanced gene therapies for focal refractory epilepsy, has announced a successful $10 million seed funding round. The financing, spearheaded by the UCL Technology Fund and bolstered by Health Technology Holding, marks a significant milestone in the company’s journey towards combating this challenging neurological disorder. Led by CEO Nicolas…

Read More

OCON Therapeutics Secures $10M to Revolutionize Women’s Health with Advanced Drug Delivery Solutions

Editor06 mins

OCON Therapeutics, a pioneer recognized by the World Economic Forum for its advancements in drug delivery, has announced a significant milestone with the completion of a $10 million investment round led by RH Capital. This funding marks a pivotal moment for OCON as it accelerates efforts to redefine the standard of care in women’s health…

Read More

Vico Therapeutics Secures €65.8 Million in Series B Funding to Advance Groundbreaking Neurological Therapies

Editor04 mins

Vico Therapeutics, a pioneering clinical-stage genetic medicines company, has successfully closed its Series B funding round with a total investment of €65.8 million ($70.7 million). This financing round, led by Seroba and Kurma Partners, marks a significant milestone in Vico’s journey towards developing transformative therapies for severe neurological diseases. Vico Therapeutics specializes in antisense oligonucleotide…

Read More

Ethris GmbH: Leading the Charge in mRNA-Based Therapeutics with $5 Million Investment

Editor04 mins

Since its inception, Ethris GmbH has been a trailblazer in mRNA technology, revolutionizing the biotech landscape with its innovative approach to respiratory and cardiovascular diseases. Founded on a vision of harnessing messenger RNA (mRNA) for therapeutic breakthroughs, Ethris has consistently pushed boundaries, drawing attention from investors and global biotech leaders alike. Breakthroughs and Strategic Growth…

Read More